According to the company, the newly founded subsidiary, Geneart Inc, is located in the San Francisco Bay Area, at the heart of one of the largest biotech clusters in the world.
Christian Ehl, CEO of Geneart AG, said: “With our two subsidiaries in Toronto, Canada and San Francisco, US, we can now offer optimum support for the biotechnology research clusters in North America.
“This benefits all researchers in the pharmaceutical and biotechnology industries as well as academic institutions working on the development of innovative biopharmaceuticals, vaccines and industrial enzymes.”